Predictors of PFOA levels in a community surrounding a chemical plant

Environmental Health Perspectives

Volumn 117, Issue 7, 2009, Pages 1083-1088

  Steenland, Kyle ^a   Jin, Chuangfang ^b   MacNeil, Jessica ^a   Lally, Cathy ^a   Ducatman, Alan ^b   Vieira, Veronica ^c   Fletcher, Tony ^d  

^a EMORY UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

PFOA; Serum levels; Water contamination

Indexed keywords

PERFLUOROOCTANOIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOLIC BEVERAGE; ARTICLE; BLOOD ANALYSIS; CHEMICAL INDUSTRY; CHILD; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD INTAKE; GEOGRAPHY; HEALTH SURVEY; HUMAN; LIFESTYLE; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SEX DIFFERENCE; UNITED STATES; WATER CONTAMINATION;

ADOLESCENT; ADULT; AGED; CHEMICAL INDUSTRY; CHILD; CHILD, PRESCHOOL; FEMALE; FLUOROCARBONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OCTANOIC ACIDS; QUESTIONNAIRES; UNITED STATES; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 67650863451     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800294     Document Type: Article

References (17)

1. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670-1676.
2. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. 2007a. Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 41:2237-2242.
3. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007b. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602.
4. Ehresman DJ, Forehlich JW, Olsen GW, Chang S-C, Butenhoff JL. 2007 Comparison of human whole blood, plasma and serum matrices for the determination of perfluoroocanesulfonate (PFOS), perfluoroctanoate (PFOA) and other fluorochemicals. Environ Res 103:176-184.
5. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. 2006. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48:759-770.
6. Fei C, McLaughlin JK, Tarone RE, Olsen J. 2007. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort Environ Health Perspect 115:1677-1682.
7. Flaherty JM, Connolly PD, Decker ER, Kennedy SM, Ellefson ME, Reagan WK, et al. 2005. Quantitative determination of perfluorooctanoic acid in serum, and plasma by liquid chromatography mass spectrometry, J Chromatogr B 819:329-338.
8. Gilliland FD, Mandel JS. 1993. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med 35(9):950-954.
9. Hölzer J, Midasch O, Rauchfuss K, Kraft M, Reupert R, Angerer J, et al. 2008. Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ Health Perspect 116:651-657.
10. Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, et al. 2004. Perflourooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38:4489-4495.
11. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. 2007. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol 18:15-20.
12. Longnecker MP, Smith CS, Kissling GE, Hoppin JA, Rutenhoff JL, Decker E, et al. 2008. An interlaboratory study of perfluorinated alkyl compounds levels in human plasma. Environ Res 107:152-159.
13. Olsen GW, Mair DC, Reagen WK. 2007. Preliminary evidence of a decline in perfluorooctanesulfonate (PFDS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 68:105-111.
14. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. 2007a. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally-exposed workers. J Occup Environ Mad 49:1086-1096.
15. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. 2007b. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med 49:872-879.
16. U.S. EPA. 2005. Draft Risk Assessment of the Potential Human Health Effects Associated with Exposure to Perflouroctanoic Acids and Its Salts. U.S. Environmental Protection Agency. Available: www.epa.gov/oppt/ pfoa/pubs/pfoarisk.htm [accessed 2 February 2009].
17. West Virginia University, Health Sciences Center. C8 Health Project Results. Available: http://www.hsc.wvu.edu/som/cmed/c8/results/index.asp [accessed 3 June 2009].